BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1016@pharmaconomics
DTSTAMP:20260707T034628Z
DTSTART;VALUE=DATE:20260401
DTEND;VALUE=DATE:20260402
SUMMARY:INBX Catalyst — ozekibart (INBRX-109)
DESCRIPTION:A key catalyst for ozekibart (INBRX-109) (conventional chondrosarcoma) is expected Apr 1\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000028/exhibit99103312026.htm\n\nTrack it: https://www.pharmaconomics.com/e/1016
URL:https://www.pharmaconomics.com/e/1016
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:INBX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR